SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (10111)10/24/1997 10:55:00 PM
From: Abuckatatime  Respond to of 32384
 
Henry, is PHOTOFRIN bringing in any revenues in Canada for LGND in the treatment of bladder, esophageal, or other cancers? And how was that deal preparatory for clinical trials and the introduction of retinoids? Clinical trials of PHOTOFRIN or clinicals for Targretin et al? I need to research the phototherapy area a bit more. It would be a pleasant surprise, for me anyway, to discover another way that LGND can make $$.